83 results
8-K
EX-1.1
BBIO
BridgeBio Pharma Inc
6 Mar 24
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
5:13pm
, enforcement, investigation, arbitration or other action from the Applicable Regulatory Authorities or any other third party alleging that any product … , is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in debarment
8-K
EX-10.2
tu064p1vld ls
25 Sep 23
BridgeBio Pharma Announces $250 Million Private Placement Equity Financing
4:00pm
8-K
EX-10.1
hf4v vga0f26zn
25 Sep 23
BridgeBio Pharma Announces $250 Million Private Placement Equity Financing
4:00pm
S-3ASR
a0cs2mt2 dyrpfr
26 Jul 23
Automatic shelf registration
4:06pm
S-3ASR
EX-4.4
odkbna dhg38hi838w98
4 May 23
Automatic shelf registration
4:55pm
S-3ASR
EX-4.5
h6wiczh
4 May 23
Automatic shelf registration
4:55pm
S-3ASR
EX-1.2
uj1vc6
4 May 23
Automatic shelf registration
4:55pm
8-K
EX-99.1
e2wt6ufy9a3 ai
4 Aug 22
BridgeBio Pharma, Inc. Reports Second Quarter 2022 Financial Results and Business Update
4:43pm